SWOG clinical trial number
S9711
A Phase II Study of IL-4 in Patients with Relapsed or Refractory B Lineage Acute Lymphoblastic Leukemia.
Closed
Phase
Accrual
10%
Abbreviated Title
A Phase II Study of IL-4 in Patients with Relapsed or Refractory B Lineage Acute Lymphoblastic Leukemia.
Activated
05/15/1997
Closed
08/15/1998
Research committees
Leukemia
Other Clinical Trials
SWOG Clinical Trial Number
S2507
A Phase II Randomized Study of Blinatumomab with or without Revumenib for Patients with KMT2A Translocation B-Cell Acute Lymphoblastic Leukemia (ALL)/ Acute Leukemia With Ambiguous Lineage (ALAL) with Persistent Measurable Residual Disease (MRD)
Research Committee(s)
Leukemia
Other
Activated
09/22/2026
Accrual
0%
Open
Phase
SWOG Clinical Trial Number
S2504
A Randomized Phase III Study of PIRtobrutinib plus R-CHOP vs. R-CHOP for Patients with Previously UntreateD RIchter TrAnsforMation (RT) (pirAMID)
Research Committee(s)
Leukemia
Lymphoma
Activated
06/01/2026
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/A042302
Phase III Evaluation of Fixed Duration Zanubrutinib Plus Sonrotoclax-Based Therapy Compared to Continuous Zanubrutinib in Previously Untreated Older Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Research Committee(s)
Leukemia
Activated
03/06/2026
Open
Phase